Department of Orthopaedics, Hull Hospital, 116 boul Lionel emond Gatineau, Quebec, Canada.
J Arthroplasty. 2011 Dec;26(8):1299-304. doi: 10.1016/j.arth.2010.12.003. Epub 2011 Feb 5.
The use of femoral head structural allograft (FHSA) for the management of massive bony defects during revision total knee arthroplasty (TKA) is well documented in the literature. The purpose of this study was to compare the clinical outcomes of patients undergoing revision (TKA) with FHSA to those without. All patients undergoing revision TKA between January 2000 and August 2005 were reviewed. Two cohorts were generated: a study cohort--revision TKA using FHSA (n = 24)--and control cohort--revision TKA without FHSA (n = 48). The 2 study cohorts groups were comparable. All patients completed validated outcome questionnaires. The FHSA cohort was found to have significantly better outcome scores. This study demonstrates improved clinical outcomes for patients undergoing revision TKA using a structural allograft compared with those without.
在翻修全膝关节置换术（TKA）中，使用股骨头结构性同种异体移植物（FHSA）来处理大量骨缺损在文献中有充分的记载。本研究的目的是比较接受翻修（TKA）并使用 FHSA 的患者与未使用 FHSA 的患者的临床结果。回顾了 2000 年 1 月至 2005 年 8 月期间接受翻修 TKA 的所有患者。生成了两个队列：研究队列-使用 FHSA 的翻修 TKA（n = 24）-和对照组-未使用 FHSA 的翻修 TKA（n = 48）。这两个研究队列组具有可比性。所有患者均完成了经过验证的结果问卷。发现使用结构性同种异体移植物的 FHSA 队列的结果评分明显更好。本研究表明，与未使用 FHSA 的患者相比，使用结构性同种异体移植物进行翻修 TKA 的患者的临床结果得到了改善。
